SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001848940-21-000001
Filing Date
2021-03-03
Accepted
2021-03-03 11:58:46
Documents
1
Effectiveness Date
2021-03-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9423
  Complete submission text file 0001848940-21-000001.txt   10460
Mailing Address 9360 TOWNE CENTRE DRIVE SAN FRANCISCO CA 92121
Business Address 9360 TOWNE CENTRE DRIVE SAN FRANCISCO CA 92121 858-926-2900
BioSplice Therapeutics, Inc. (Filer) CIK: 0001848940 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-391093 | Film No.: 21707807